miR‐486‐5p Inhibits eNOS and Angiogenesis in Cultured Endothelial Cells by Targeting MAML3
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70589 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Adrianna Douvris und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine and Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario,…. Hauptthemen laut MEDLINE: Nitric Oxide Synthase Type III, MicroRNAs, Neovascularization, Physiologic, DNA-Binding Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Jones Family Foundation at the Ottawa Hospital Foundation, Kidney Foundation of Canada.
Abstract (Originalsprache)
Kidney ischemia–reperfusion (I/R) is associated with endothelial injury. Administration of miRNA (miR)‐486‐5p protects against rat kidney I/R injury, with localisation to capillary endothelial cells, although it inhibits I/R‐induced endothelial nitric oxide synthase (eNOS) protein expression. Here, we studied the effect of miR‐486‐5p on eNOS and endothelial cell function and determined its mRNA targets. Human umbilical vein endothelial cells (HUVECs) were transfected with the miR‐486‐5p mimic and assayed for proliferation, migration and network formation. Biotinylated miR‐486‐5p was transfected for pulldown of bound mRNA, followed by RNA sequencing. miR‐486‐5p markedly decreased eNOS mRNA and protein in HUVECs ( p < 0.001) and decreased eNOS protein in human pulmonary microvascular endothelial cells ( p < 0.05), although eNOS was not a direct target of miR‐486‐5p. miR‐486‐5p inhibited angiogenesis, which was rescued with eNOS plasmid transfection. RNA sequencing of biotinylated miR‐486‐5p pulldown RNA revealed highly significant enrichment in predicted targets FOXO1, FOXP1, TNFSF4, MAML3 and CELSR3, and in the non‐predicted target SPCS2. RT‐qPCR validated these transcripts as inhibited by miR‐486‐5p. While silencing of FOXO1 had no impact on eNOS protein, MAML3 silencing inhibited eNOS levels. miR‐486‐5p inhibits angiogenesis in endothelial cells via eNOS down‐regulation, which involves selective targeting of MAML3. These data support a novel pathway regulating endothelial cell function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine and Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
- Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- Ottawa Bioinformatics Core Facility, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
ORCID-Profile: Adrianna Douvris, Ali Maadelat, Christopher J Porter, Dylan Burger, Kevin D Burns
Förderung
- CIHR
- Jones Family Foundation at the Ottawa Hospital Foundation
- Kidney Foundation of Canada
- Canadian Institutes of Health Research
Zitieren
APA
Douvris, A., Maadelat, A., Porter, C. J., Burger, D., & Burns, K. D. (2025). miR‐486‐5p Inhibits eNOS and Angiogenesis in Cultured Endothelial Cells by Targeting MAML3. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70589
Vancouver
Douvris A, Maadelat A, Porter CJ, Burger D, Burns KD. miR‐486‐5p Inhibits eNOS and Angiogenesis in Cultured Endothelial Cells by Targeting MAML3. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70589
BibTeX
@article{Douvris2025,
author = {Douvris, Adrianna and Maadelat, Ali and Porter, Christopher J and Burger, Dylan and Burns, Kevin D},
title = {miR‐486‐5p Inhibits eNOS and Angiogenesis in Cultured Endothelial Cells by Targeting MAML3},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70589}
}
EUVIMED